ESTRO 38 - Programme Book & Exhibition Guide

Management of high-risk prostate cancer Friday 26 April 2019 | 09:00-17:15 | room Ambra 8

Course directors: A.Bossi (FR) and G. De Meerleer (BE) Course teachers: A. Briganti (IT), C. Cozzarini (IT), V. Fonteyne (BE), P. Hoskin (UK), S. Joniau (BE), R. Renard-Penna (FR)

Course aim To provide an up-date of the current challenges related to the diagnosis and management of High Risk prostate cancer patients with specific emphasis on the role of EBRT and brachytherapy, whether or not within a multimodality approach. Learning objectives The most important learning objective will be to recognise the need of a fully multidisciplinary approach in the diagnosis and treatment of patients diagnosed with High Risk Prostate cancer. In details, after participating to this course attendees will be able: • to summarise the current evidences related to the recent definition and diagnosis of High Risk disease • to discuss the modern treatment options • to explain the rapidly changing paradigm in the association between drugs and irradiation • to identify the most frequent toxicity related to the different management options • to discuss the current and future treatment approaches.

Target audience Radiation oncologists, surgeons with a special interest in urology, medical oncologists, RT physicists, RTTs and RT nurses.

Programme 09:00

Pre-meeting starts

>

09:00-09:30 >

The definition of HRPCa in 2019 S. Joniau (BE)

09:30-10:00 >

Local and distant staging of HRPCa: the role of MRI R. Renard-Penna (FR)

10:00-10:30 >

Beyond Gleason score and PSA A. Briganti (IT)

PROGRAMME | Programme and Exhibition Guide

58